Genetic analysis of pancreatic cancer has indicated that multiple mutations accumulate over time, including KRAS (about 90%), p16/ INK4a/CDKN2A (about 75%), TP53 (about 65%), and SMAD4 (about 50%)] [1,2]. Here, KRAS is linked to pancreatic neoplasm.